Science
Mechanism of Action
This peptide operates via a dual-action pathway: it inhibits the expression of pro-inflammatory cytokines to calm surface irritation while simultaneously stimulating the synthesis of collagen, laminin, and keratinocytes at the structural level to fortify the skin barrier.
Research
Clinical Evidence
High confidence2%
Key findings
- 01 Clinical trials at 0.5%-2% demonstrated measurable reductions in skin scaling and roughness with visible texture improvements within 4 to 14 weeks.
- 02 In vivo testing at 1% concentration confirmed increased lash density and hair growth by promoting adhesion molecules in the dermal sheath.
- 03 High-concentration studies (2%-8%) showed potent inhibition of cytokines, effectively reducing neuropathic edema and chronic irritation.
Transparency
Dusting Analysis
Avena Sativa Peptide is frequently used in trace amounts for marketing 'oat-based' soothing claims; however, clinical data suggests a minimum of 0.5% is required for texture benefits and at least 2% for significant anti-inflammatory performance.
The Formula
Formulation
Stability
Thermolabile; must be incorporated during the cool-down phase of formulation at temperatures below 40°C. For maximum longevity, aqueous solutions should be stored between 2-8°C and shielded from light.
Synergies
- Ceramides
- Hyaluronic Acid
- Panthenol
Conflicts
- Strong oxidizing agents
- Processing temperatures exceeding 40°C
Safety
Safety Profile
Oat-derived peptides have an extensive history of safe use in both food and topical applications; they are generally non-sensitizing and well-tolerated by reactive skin.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A highly versatile, low-irritancy peptide that excels at reinforcing skin architecture while providing rapid relief for sensitive or compromised barriers.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources